Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-29-Speech-4-214"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-11-29"^^xsd:date2
dcterms:Is Part Of	lp_eu:Vote2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20011129.2.4-214"2
lpv:hasSubsequent	lp_eu:2001-11-29-Speech-4-2152
lpv:speaker	lp:Astrid Lulling2
lpv:spokenAs	member; Delegation for relations with the countries of South America and MERCOSUR (1999-10-06--2002-01-14)3 member; EPP-ED (1999-09-16--2004-07-19)3 unknown; Parti chrétien social (1999-09-16--2004-07-19)3 substitute; AGRI (1999-10-07--2002-01-14)3 member; Committee on Women's Rights and Equal Opportunities (1999-10-07--2002-01-14)3 member; ECON (1999-10-07--2002-01-14)3
lpv:translated text	". I voted in favour of the 1998 directive on legal protection for biotechnological inventions, which I considered to be in order, although, like most of the texts we vote on, it certainly leaves room for improvement. It is, however, necessary, as we cannot allow there to be a legal vacuum on this subject in the European Union if we want to stay competitive in international research, which we certainly will not if we do not give legal protection to inventions in the field of biotechnology and freedom to research. Such freedom, however, must not lead to the erosion of ethical boundaries. The hope of sufferers that there will be treatment for their as yet incurable diseases leads me to believe that even the Church must be open-minded about putting in place, and making use of, new methods of treating chronically sick people. Research using existing stem cells, and the promotion of it (also favoured by President Bush of the USA) should be permitted in basic research throughout Europe. Research on adult and foetal stem cells should, however, be given priority. The use of stem cells for therapeutic purposes is marching on as a potentially revolutionary new method for treating diseases and injuries. The therapeutic objective is to develop differentiated cells or permanent tissues for transplantation into patients with diabetes, Alzheimer's and Parkinson's diseases, heart attacks etc., conditions for which there are, at present, no effective therapies or treatments. It is, in any case, clear to me that this should involve only stem cell lines which have already been produced and which can be suspended in a culture in which they can proliferate. For me, erosion of the ethical boundary begins with the deliberate breeding of embryos for research purposes. That must not be permitted."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph